Effect of HGF-like basic hexapeptides on angiogenesis

被引:11
作者
Fazekas, K [1 ]
Janovics, A
Döme, B
Koska, P
Albini, A
Tímár, J
机构
[1] Natl Inst Oncol, Dept Tumor Progress, H-1122 Budapest, Hungary
[2] Semmelweis Univ, Fac Hlth Sci, Dept Ophthalmol, H-1085 Budapest, Hungary
[3] Semmelweis Univ, Inst Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary
[4] Natl Inst Psychiat & Neurol, Budapest, Hungary
[5] Ist Nazl Ric Canc, I-16132 Genoa, Italy
关键词
basic peptides; HGF beta-chain; endothelial cells; CAM assay; tumor-induced angiogenesis;
D O I
10.1006/mvre.2001.2354
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
The interaction of glycosaminoglycans (GAG) with peptides relies on noncovalent binding to basic amino acid sequences, for which a minimal requirement is a pentapeptide region in the protein and the sulfated and carboxyl region in the GAG. Since such sequences are present in the heparin-binding angiogenic cytokines, including hepatocyte growth factor (HGF), we have postulated that such small peptides may have biological activity. Two basic peptide regions of the β chain of HGF (RYRNKH512-516, HHRGK645-649) exhibited significant anti-angiogenic activity in viva in the chorioallantoic membrane assay and showed some antiproliferative activity in vitro on normal human brain microvessel endothelial - but not on anchorage-independent endothelial - cells (Kaposi sarcoma). Basic HIV-TAT peptides and scrambled hexapeptides did not show similar activity, except for KRKRKR, indicating sequence specificity of the phenomena. An HGF-derived basic peptide, HHRGK, modulated tumor-induced angiogenesis in viva by interfering with the morphogenic, but not with the proliferative, phase of the process. These observations suggest small basic peptides as a new class of angiogenesis modulators. © 2001 Academic Press.
引用
收藏
页码:440 / 444
页数:5
相关论文
共 22 条
[1]
The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line [J].
Albini, A ;
Paglieri, I ;
Orengo, G ;
Carlone, S ;
Aluigi, MG ;
DeMarchi, R ;
Matteucci, C ;
Mantovani, A ;
Carozzi, F ;
Donini, S ;
Benelli, R .
AIDS, 1997, 11 (06) :713-721
[2]
Identification of a novel domain of HIV Tat involved in monocyte chemotaxis [J].
Albini, A ;
Benelli, R ;
Giunciuglio, D ;
Cai, T ;
Mariani, G ;
Ferrini, S ;
Noonan, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :15895-15900
[3]
Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of hepatocyte growth factor [J].
Aoyama, H ;
Naka, D ;
Yoshiyama, Y ;
Ishii, T ;
Kondo, J ;
Mitsuka, M ;
Hayase, T .
BIOCHEMISTRY, 1997, 36 (33) :10286-10291
[4]
Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis [J].
Bae, DG ;
Gho, YS ;
Yoon, WH ;
Chae, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13588-13596
[5]
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[6]
REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[7]
Role of soluble mediators in angiogenesis [J].
Bussolino, F ;
Albini, A ;
Camussi, G ;
Presta, M ;
Viglietto, G ;
Ziche, M ;
Persico, G .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2401-2412
[8]
New paradigms for the treatment of cancer: The role of anti-angiogenesis agents [J].
Cherrington, JM ;
Strawn, LM ;
Shawver, LK .
ADVANCES IN CANCER RESEARCH, VOL 79, 2000, 79 :1-38
[9]
The vascular architecture of the chick chorioallantoic membrane: Sequential quantitative evaluation using corrosion casting [J].
Dimitropoulou C. ;
Malkusch W. ;
Fait E. ;
Maragoudakis M.E. ;
Konerding M.A. .
Angiogenesis, 1998, 2 (3) :255-263
[10]
FAZEKAS K, 2001, IN PRESS CLIN EXP ME